Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-ε4 carriers

Journal of Human Genetics

Volumn 53, Issue 4, 2008, Pages 296-302

  Aidaralieva, Nuripa Jenishbekovna ^a   Kamino, Kouzin ^a   Kimura, Ryo ^a   Yamamoto, Mitsuko ^a   Morihara, Takeshi ^a   Kazui, Hiroaki ^a   Hashimoto, Ryota ^a   Tanaka, Toshihisa ^a   Kudo, Takashi ^a   Kida, Tomoyuki ^b   Okuda, Jun Ichiro ^b   Uema, Takeshi ^c   Yamagata, Hidehisa ^d   Miki, Tetsuro ^d   Akatsu, Hiroyasu ^e   Kosaka, Kenji ^e   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Shoraiso National Hospital   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Alzheimer; Apolipoprotein E; Association; Chromosome 19p; Dynamin 2; Genetic risk

Indexed keywords

APOLIPOPROTEIN E; BETA SECRETASE; DYNAMIN I; DYNAMIN II;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 19P; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; DYNAMIN II; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 41549131667     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-008-0251-9     Document Type: Article

References (27)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
2. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE; NIMH Genetics Initiative Alzheimer's Disease Study Group (2003) Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12:23-32
3. Chyung JH, Selkoe DJ (2003) Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid β-protein at the cell surface. J Biol Chem 278:51035-51043
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
5. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 278:1349-1356
6. Fukumori A, Okochi M, Tagami S, Jiang J, Itoh N, Nakayama T, Yanagida K, Ishizuka-Katsura Y, Morihara T, Kamino K, Tanaka T, Kudo T, Tanii H, Ikuta A, Haass C, Takeda M (2006) Presenilin-dependent gamma-secretase on plasma membrane and endosomes is functionally distinct. Biochemistry 45:4907-4914
7. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225-2229
8. Gutala RV, Reddy PH (2004) The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J Neurosci Methods 132:101-107
9. Hedrick PW (1987) Gametic disequilibrium measures: proceed with caution. Genetics 117:331-341
10. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R (1997) Genetic association of the low-density lipoprotein receptor-related protein (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49:56-61
11. Kelly BL, Vassar R, Ferreira A (2005) β-amyloid-induced dynamin 1 depletion in hippocampal neurons. J Biol Chem 280:31746-31753
12. Kolsch H, Lutjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R (2002) Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease. Mol Psychiatry 7:899-902
13. Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y; The Japanese Genetic Study Consortium for Alzheimer's Disease (2006) Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease. Hum Mol Genet 15:2170-2182
14. McKhann G., Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease; report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944
15. Nyholt DR (2004) A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet 74:765-769
16. Obar RA, Collins CA, Hammarback JA, Shpetner HS, Vallee RB (1990) Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins. Nature 347:256-261
17. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278:1237-1241
18. Praefcke GJ, McMahon HT (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 5:133-147
19. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York, pp 9.14-9.19
20. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
21. Shpetner HS, Vallee RB (1989) Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules. Cell 59:421-432
22. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102
23. Suzuki DT, Grigliatti T, Williamson R (1971) Temperature-sensitive mutations in Drosophila melanogaster. VII. A mutation (para-ts) causing reversible adult paralysis. Proc Natl Acad Sci USA 68:890-893
24. Wenham PR, Price WH, Blandell G. (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337:1158-1159
25. Wijsman EM, Daw EW, Yu CE, Payami H, Steinbart EJ, Nochlin D, Conlon EM, Bird TD, Schellenberg GD (2004) Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75:398-409
26. Yao PJ (2004) Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease. Trends Neurosci 27:24-29
27. Zuchner S, Noureddine M, Kennerson M, Verhoeven K, Claeyes K, De Jonghe P, Merory J, Oliveira SA, Speer MC, Stenger JE, Walizada G, Zhu D, Pericak-Vance MA, Nicholson G, Timmerman V, Vance JM (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37:289-294